ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 585

Relative Overexpression of Membrane-Bound Versus Soluble TNF in Human and Experimental Spondyloarthritis

Carmen Ambarus1, Leonie M. van Duivenvoorde1, Huriatul Masdar1, Melissa N. van Tok2, Paul P. Tak1, Nataliya Yeremenko3 and Dominique L. Baeten3, 1Clinical Immunology and Rheumatology, Academic Medical Center / University of Amsterdam, Amsterdam, Netherlands, 2Division of Clinical Immunology and Rheumatology and Department of Experimental Immunology, Academic Medical Center / University of Amsterdam, Amsterdam, Netherlands, 3Division of Clinical Immunology and Rheumatology, Academic Medical Center/University of Amsterdam, Amsterdam, Netherlands

Meeting: 2012 ACR/ARHP Annual Meeting

Keywords: Animal models, Ankylosing spondylitis (AS) and tumor necrosis factor (TNF)

  • Tweet
  • Email
  • Print
Session Information

Title: Spondylarthritis and Psoriatic Arthritis - Pathogenesis, Etiology

Session Type: Abstract Submissions (ACR)

Background/Purpose: Macrophages and their pro-inflammatory cytokines, including TNF, are pivotal mediators of chronic synovitis in rheumatoid arthritis (RA) as well as spondyloarthritis (SpA). Despite similar levels of synovial macrophage infiltration and similar clinical responses to TNF blockade in both diseases, SpA is characterized by a more pronounced infiltration with alternatively activated CD163+ macrophages and ongoing osteoproliferation. This study aimed to investigate whether these differences were related to a differential expression and/or function of TNF between both diseases.

Methods: Healthy donor peripheral blood-derived monocytes were polarized in vitro by IFN-γ, IL-4 or IL-10 for 4 days. The expression of membrane-bound TNF (mTNF) and soluble TNF (sTNF) was measured by FACS and ELISA, respectively. Expression of TNF and its receptors was also measured by qPCR and ELISA in synovial fluid (SF) and synovial tissue biopsies (ST) of actively inflamed knee joints of SpA and RA patients. Mice transgenically overexpressing mTNF (TgA86) were evaluated clinically and histologically for spondylitis and peripheral arthritis.

Results: The expression of mTNF was increased in IL-10 and IL-4 polarized macrophages (alternatively activated macrophages) in comparison with IFN-γ polarized cells (classical activated macrophages). Moreover, the production of sTNF was clearly impaired in the IL-10 polarized CD163+ macrophages and IL-4 polarized macrophages (p<0.01 versus IFN-γ polarized macrophages), indicating a relative shift from sTNF to mTNF by alternative macrophage activation. In line with these in vitro data, the sTNF SF levels were significantly lower in SpA compared to RA (p=0.01) despite similar TNF mRNA levels in ST. This was not related to altered expression of TNF receptors as both TNF-R1 and TNF-R2 were similarly expressed in ST, both at protein and mRNA levels. The mRNA levels of TACE, the enzyme responsible for the cleavage of TNF, TNF receptors and other molecules from the cell membrane were also similar between SpA and RA ST. To investigate whether relative overexpression of mTNF could be relevant in SpA pathophysiology, we characterized mTNF transgenic mice. As previously described, these mice developed a moderate peripheral arthritis with 100% incidence, resulting in deformation of the paws and loss of grip strength. Histologically, the joints were characterized by moderate synovitis and appearance of lymphoid aggregates in the bone marrow, mostly in the absence of osteoclastic infiltration or extensive destruction. Besides arthritis, all transgenic animals spontaneously developed spondylitis as evidenced by a crinkled tail, a hunchback and histological inflammation in the connective tissue next to the intervertebral disc. Interestingly, also bone remodeling was observed both in axial and peripheral joints. None of the non-transgenic littermates developed signs of arthritis and/or spondylitis.

Conclusion: mTNF is relatively overexpressed by CD163+ alternatively polarized macrophages in SpA synovitis and leads to an axial and peripheral SpA phenotype in transgenic mice, including osteoproliferation.


Disclosure:

C. Ambarus,
None;

L. M. van Duivenvoorde,
None;

H. Masdar,
None;

M. N. van Tok,
None;

P. P. Tak,
None;

N. Yeremenko,
None;

D. L. Baeten,
None.

  • Tweet
  • Email
  • Print

« Back to 2012 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/relative-overexpression-of-membrane-bound-versus-soluble-tnf-in-human-and-experimental-spondyloarthritis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology